Jason Schwartz is an assistant professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jason Schwartz . (2020). Interview with Dr. Jason Schwartz on processes for determining the safety and efficacy of Covid-19 vaccine candidates and for distributing vaccines.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005882&aid=10.1056%2FNEJMp2029479&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

Beautyberry leaf extract restores drug’s power to fight ‘superbug’

According to an article recently shared by…

La inteligencia artificial produce nuevos antibióticos

Investigadores del Instituto de Tecnología de…

New treatment for drug-resistant bacterial infections

ScienceDaily has recently reported on a study by…

US hospitals lost $22.3B delaying elective surgeries, study estimates

As a result of the pandemic, a study shared by…

Hospital superbug traced to remote island beach

According to SciDev.Net, researchers have…

La contaminación plástica puede estar extendiendo la resistencia a los antibióticos

Según una nueva investigación, compartida por la…